ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Global Gene Therapy Research Report 2018 Featuring CRISPR-Cas9 and CAR-T Cell Therapies – PR Newswire (press release)

Global Gene Therapy Research Report 2018 Featuring CRISPR-Cas9 and CAR-T Cell TherapiesPR Newswire (press release)There is an introduction to technologies for gene suppression as well as molecular diagnostics to detect and monitor gene expression. Gene… Continue reading

2018-05-30 Michael Zand NEWS

Focusing On You: CAR-T Therapy At Sylvester Comprehensive Cancer Center – CBS Miami

Continue reading

2018-05-30 Michael Zand NEWS

“Reprogrammed” Stem Cells Approved to Mend Human Hearts in Pilot Study – Scientific American

Scientific American“Reprogrammed” Stem Cells Approved to Mend Human Hearts in Pilot StudyScientific AmericanScientists in Japan now have permission to treat people who have heart disease with cells produced by a revolutionary reprogramming technique. … Continue reading

2018-05-30 Michael Zand NEWS

A single cell spurs 5-year remission for Penn leukemia patient – PhillyVoice.com

PhillyVoice.comA single cell spurs 5-year remission for Penn leukemia patientPhillyVoice.comA single CAR T cell, reprogrammed to recognize and kill cancer, kick-started a path to remission for a leukemia patient treated at the Abramson Cancer Center at… Continue reading

2018-05-30 Michael Zand NEWS

ASCO 2018: Top Oncologists Select Key, Practice-Changing Abstracts – OncLive

OncLiveASCO 2018: Top Oncologists Select Key, Practice-Changing AbstractsOncLivePhase I results of this study previously showed that treatment with the CAR T-cell product JCAR017 demonstrated a CR rate of 59% and an ORR of 86% for patients with relapse… Continue reading

2018-05-30 Michael Zand NEWS

UCSF Doctors Transplant Stem Cells Into Ailing Fetus – CBS San Francisco


CBS Miami

Focusing On You: CAR–T Therapy At Sylvester Comprehensive Cancer Center
CBS Miami
The trial was for CAR–T Cell Therapy, a type of immunotherapy that uses a patient’s own immune system to fight cancer. In January, the Federal Drug Administration (FDA) approved two forms of CAR-T therapy for the treatment of advanced blood cancers in …

Continue reading

2018-05-30 Michael Zand NEWS

We Can Now Treat Sick Babies With Stem Cells Before They’re Even Born – Futurism


CBS San Francisco

UCSF Doctors Transplant Stem Cells Into Ailing Fetus
CBS San Francisco
At UCSF, Dr. MacKenzie has spent more than 10 years developing a procedure to do a stem cell transplant at the same time as the necessary blood transfusions inside the womb. The procedure uses the mother’s stem cells. “We made the discovery that the …
We Can Now Treat Sick Babies With Stem Cells Before They’re Even BornFuturism

all 3 news articles »

Continue reading

2018-05-30 Michael Zand NEWS

Mustang Bio’s optimized CAR-T therapy shows encouraging action in preclinical testing; shares ahead 3% – Seeking Alpha


Futurism

We Can Now Treat Sick Babies With Stem Cells Before They’re Even Born
Futurism
Statistically, baby Elianna had little chance of survival. During an ultrasound, the doctor caring for Elianna’s mother, Nichelle Obar, realized the woman’s fetus suffered from a blood disorder called alpha thalassemia major. Usually, fetuses with the …
UCSF Doctors Transplant Stem Cells Into Ailing FetusCBS San Francisco

all 3 news articles »

Continue reading

2018-05-30 Michael Zand NEWS
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

registrarjournal.com

Mustang Bio’s optimized CAR–T therapy shows encouraging action in preclinical testing; shares ahead 3%
Seeking Alpha
The study, conducted at the City of Hope National Medical Center, showed a greater antitumor effect for Mustang’s CD4+ CAR T cells compared to CD8+ CAR T cells. A Phase 1 trial in glioblastoma, the most aggressive type of brain tumor, is ongoing.
Mustang Bio (NASDAQ:MBIO) Lifted to “Buy” at Zacks Investment ResearchStockNewsTimes

all 2 news articles »